The Indian Pharmaceutical Intellectual Property Rights (IPR) consulting market is seeing huge growth due to the growing pharmaceutical industry and the increasing importance of intellectual property (IP) protection. India's pharmaceutical industry is undergoing rapid change, and is a leading global force in healthcare, particularly through generic drug production, but is increasingly affected by patent laws, innovation, and access to cost effective medicines. As companies navigate complex patent regulations, in particular following India’s obligations under the World Trade... >>More
Prof. (Dr) Mahipal Sachdev, Chairman, Centre for Sight
Shivam Singhee, Co-Founder & CEO, Awshad
Sandhya Sriram, Group CFO, Narayana Health
Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre
Satish Agrawal, President (Tech. & Oprns), Ajanta Pharma
Dr. Shirish Alurkar- Sr. Consultant- Medical Oncology, HCG Cancer Centre